
Reducing inflammation without lowering cholesterol cuts risk of cardiovascular events
Inflammatory hypothesis confirmed: Landmark randomized clinical trial of high-risk patients finds that a drug targeting inflammation reduced risk of major adverse cardiovascular events. Investigators from Brigham and Women's Hospital today announced results of a...

Poor sleep is associated with ischemic heart disease and stroke
Poor sleep is associated with ischaemic heart disease and stroke, according to research presented at ESC Congress 2017 in Barcelona, Spain. The observational study in nearly 13,000 people revealed different patterns of sleep disturbance between the two conditions,...

Stroke patient improvement with a brain-computer interface
University of Adelaide researchers have shown that it is possible for stroke patients to improve motor function using special training involving connecting brain signals with a computer. In a "proof-of-principle" study published in the journal Royal Society Open...

How low should LDL cholesterol go?
New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to <10 mg/dL, safely results in additional lowering of risk of cardiovascular events. A newer class of cholesterol lowering drugs known as PCSK9 inhibitors has...

Anticoagulants used for arrhythmia can have different thrombus formation rates
Anticoagulants are recommended for atrial fibrillation due to the high risk of stroke. However, bleeding complications can occur as a side effect. Researchers in Japan examined several types of anticoagulants and found that the rates of thrombus formation are...